Induction of heme oxygenase-1 with dietary quercetin reduces obesity-induced hepatic inflammation through macrophage phenotype switching
1
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
BACKGROUND/OBJECTIVES: Obesity-induced steatohepatitis accompanied by activated hepatic macrophages/Kupffer cells facilitates the progression of hepatic fibrinogenesis and exacerbates metabolic derangements such as insulin resistance. Heme oxyganase-1 (HO-1) modulates tissue macrophage phenotypes and thus is implicated in protection against inflammatory diseases. Here, we show that the flavonoid quercetin reduces obesity-induced hepatic inflammation by inducing HO-1, which promotes hepatic macrophage polarization in favor of the M2 phenotype. MATERIALS/METHODS: Male C57BL/6 mice were fed a regular diet (RD), high-fat diet (HFD), or HFD supplemented with quercetin (HF+Que, 0.5g/kg diet) for nine weeks. Inflammatory cytokines and macrophage markers were measured by ELISA and RT-PCR, respectively. HO-1 protein was measured by Western blotting. RESULTS: Quercetin supplementation decreased levels of inflammatory cytokines (TNFα, IL-6) and increased that of the anti-inflammatory cytokine (IL-10) in the livers of HFD-fed mice. This was accompanied by upregulation of M2 macrophage marker genes (Arg-1, Mrc1) and downregulation of M1 macrophage marker genes (TNFα, NOS2). In co-cultures of lipid-laden hepatocytes and macrophages, treatment with quercetin induced HO-1 in the macrophages, markedly suppressed expression of M1 macrophage marker genes, and reduced release of MCP-1. Moreover, these effects of quercetin were blunted by an HO-1 inhibitor and deficiency of nuclear factor E2-related factor 2 (Nrf2) in macrophages. CONCLUSIONS: Quercetin reduces obesity-induced hepatic inflammation by promoting macrophage phenotype switching. The beneficial effect of quercetin is associated with Nrf2-mediated HO-1 induction. Quercetin may be a useful dietary factor for protecting against obesity-induced steatohepatitis.
Abstract
BACKGROUND/OBJECTIVES: Obesity-induced steatohepatitis accompanied by activated hepatic macrophages/Kupffer cells facilitates the progression of hepatic fibrinogenesis and exacerbates metabolic derangements such as insulin resistance. Heme oxyganase-1 (HO-1) modulates tissue macrophage phenotypes and thus is implicated in protection against inflammatory diseases. Here, we show that the flavonoid quercetin reduces obesity-induced hepatic inflammation by inducing HO-1, which promotes hepatic macrophage polarization in favor of the M2 phenotype. MATERIALS/METHODS: Male C57BL/6 mice were fed a regular diet (RD), high-fat diet (HFD), or HFD supplemented with quercetin (HF+Que, 0.5g/kg diet) for nine weeks. Inflammatory cytokines and macrophage markers were measured by ELISA and RT-PCR, respectively. HO-1 protein was measured by Western blotting. RESULTS: Quercetin supplementation decreased levels of inflammatory cytokines (TNFα, IL-6) and increased that of the anti-inflammatory cytokine (IL-10) in the livers of HFD-fed mice. This was accompanied by upregulation of M2 macrophage marker genes (Arg-1, Mrc1) and downregulation of M1 macrophage marker genes (TNFα, NOS2). In co-cultures of lipid-laden hepatocytes and macrophages, treatment with quercetin induced HO-1 in the macrophages, markedly suppressed expression of M1 macrophage marker genes, and reduced release of MCP-1. Moreover, these effects of quercetin were blunted by an HO-1 inhibitor and deficiency of nuclear factor E2-related factor 2 (Nrf2) in macrophages. CONCLUSIONS: Quercetin reduces obesity-induced hepatic inflammation by promoting macrophage phenotype switching. The beneficial effect of quercetin is associated with Nrf2-mediated HO-1 induction. Quercetin may be a useful dietary factor for protecting against obesity-induced steatohepatitis.
참고문헌 (33)
- Bilzer M, "Role of Kupffer cells in host defense and liver disease", Liver Int, 26, pp.1175~1186 (2006)
- Li Z, "Innate immunity in the liver", Curr Opin Gastroenterol, 19, pp.565~571 (2003)
- Lanthier N, "Kupffer cell activation is a causal factor for hepatic insulin resistance", Am J Physiol Gastrointest Liver Physiol, 298, pp.G107~G116 (2010)
- Mantovani A, "The chemokine system in diverse forms of macrophage activation and polarization", Trends Immunol, 25, pp.677~686 (2004)
- Lumeng CN, "Obesity induces a phenotypic switch in adipose tissue macrophage polarization", J Clin Invest, 117, pp.175~184 (2007)
- Dixon LJ, "Kupffer cells in the liver", Compr Physiol, 3, pp.785~797 (2013)
- Odegaard JI, "Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance", Cell Metab, 7, pp.496~507 (2008)
- Wan J, "M2Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease", Hepatology, 59, pp.130~142 (2014)
- Alam J, "Nrf2, a Cap'n'Collar transcription factor, regulates induction of the heme oxygenase-1 gene", J Biol Chem, 274, pp.26071~26078 (1999)
- Lee TS, "Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice", Nat Med, 8, pp.240~246 (2002)
- Ndisang JF., "Role of heme oxygenase in inflammation, insulinsignalling, diabetes and obesity", Mediators Inflamm, 2010, pp.359732~ (2010)
- Kim DH, "Heme oxygenase-mediated increases in adiponectin decrease fat content and inflammatory cytokines tumor necrosis factor-alpha and interleukin-6 in Zucker rats and reduce adipogenesis in human mesenchymal stem cells", J Pharmacol Exp Ther, 325, pp.833~840 (2008)
- L'Abbate A, "Beneficial effect of heme oxygenase-1 expression on myocardial ischemia-reperfusion involves an increase in adiponectin in mildly diabetic rats", Am J Physiol Heart Circ Physiol, 293, pp.H3532~H3541 (2007)
- Alcaraz MJ, "Anti-inflammatory actions of the heme oxygenase-1 pathway", Curr Pharm Des, 9, pp.2541~2551 (2003)
- Tu TH, "Induction of heme oxygenase-1 with hemin reduces obesity-induced adipose tissue inflammation via adipose macrophage phenotype switching", Mediators Inflamm, 2014, pp.290708~ (2014)
- Yao P, "The protective role of HO-1 and its generated products (CO, bilirubin, and Fe) in ethanol-induced human hepatocyte damage", Am J Physiol Gastrointest Liver Physiol, 296, pp.G1318~G1323 (2009)
- Son Y, "Therapeutic roles of heme oxygenase-1 in metabolic diseases: curcumin and resveratrol analogues as possible inducers of heme oxygenase-1", Oxid Med Cell Longev, 2013, pp.639541~ (2013)
- Anjaneyulu M, "Quercetin, an anti-oxidant bioflavonoid, attenuates diabetic nephropathy in rats", Clin Exp Pharmacol Physiol, 31, pp.244~248 (2004)
- Overman A, "Quercetin attenuates inflammation in human macrophages and adipocytes exposed to macrophage-conditioned media", Int J Obes (Lond), 35, pp.1165~1172 (2011)
- Panchal SK, "Quercetin ameliorates cardiovascular, hepatic, and metabolic changes in diet-induced metabolic syndrome in rats", J Nutr, 142, pp.1026~1032 (2012)
- 노혜지, "Quercetin Suppresses MIP-1a–Induced Adipose Inflammation by Downregulating Its Receptors CCR1", CCR5 and Inhibiting Inflammatory Signaling, 2014, pp.17(5), 550~557[DOI]
- Le NH, "Quercetin protects against obesityinduced skeletal muscle inflammation and atrophy", Mediators Inflamm, 2014, pp.834294~ (2014)
- Ying HZ, "Dietary quercetin ameliorates nonalcoholic steatohepatitis induced by a high-fat diet in gerbils", Food Chem Toxicol, 52, pp.53~60 (2013)
- Li X, "Quercetin improves insulin resistance and hepatic lipid accumulation in vitro in a NAFLD cell model", Biomed Rep, 1, pp.71~76 (2013)
- Marcolin E, "Quercetin treatment ameliorates inflammation and fibrosis in mice with nonalcoholic steatohepatitis", J Nutr, 142, pp.1821~1828 (2012)
- 김추숙, "고지방 식이로 유도된 비만쥐에서 Quercetin의 지방조직 염증개선 효과", Journal of Obesity & Metabolic Syndrome, 23(3), pp.170~178 (2014), 대한비만학회
- Lin HY, "Inhibition of lipopolysaccharide-induced nitric oxide production by flavonoids in RAW264.7 macrophages involves heme oxygenase-1", Biochem Pharmacol, 66, pp.1821~1832 (2003)
- Marra F, "Pathophysiology of NASH: perspectives for a targeted treatment", Curr Pharm Des, 19, pp.5250~5269 (2013)
- Tosello-Trampont AC, "Kuppfer cells trigger nonalcoholic steatohepatitis development in diet-induced mouse model through tumor necrosis factoralpha production", J Biol Chem, 287, pp.40161~40172 (2012)
- Dong J, "Quercetin reduces obesity-associated ATM infiltration and inflammation in mice: a mechanism including AMPKalpha1", SIRT1, 2014, pp.55, 363~374
- Matsuzawa N, "Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet", Hepatology, 46, pp.1392~1403 (2007)
- Kim CS, "Quercetin reduces obesity-induced hepatosteatosis by enhancing mitochondrial oxidative metabolism via heme oxygenase-1", Nutr Metab (Lond), 12, pp.33~ (2015)
- Endale M, "Quercetin disrupts tyrosine-phosphorylated phosphatidylinositol 3-kinase and myeloid differentiation factor-88 association, and inhibits MAPK", AP-1 and IKK, Immunobiology, pp.2013, 218[DOI]